nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Uveitis—Alendronate—osteoporosis	0.0365	0.0365	CcSEcCtD
Metipranolol—Uveitis—Ibandronate—osteoporosis	0.0356	0.0356	CcSEcCtD
Metipranolol—Uveitis—Risedronate—osteoporosis	0.0293	0.0293	CcSEcCtD
Metipranolol—Uveitis—Pamidronate—osteoporosis	0.0279	0.0279	CcSEcCtD
Metipranolol—Uveitis—Zoledronate—osteoporosis	0.0254	0.0254	CcSEcCtD
Metipranolol—Bradycardia—Calcium Acetate—osteoporosis	0.0117	0.0117	CcSEcCtD
Metipranolol—Photophobia—Calcitriol—osteoporosis	0.0114	0.0114	CcSEcCtD
Metipranolol—Arthritis—Etidronic acid—osteoporosis	0.0112	0.0112	CcSEcCtD
Metipranolol—Blepharitis—Estradiol—osteoporosis	0.0111	0.0111	CcSEcCtD
Metipranolol—Arthritis—Raloxifene—osteoporosis	0.00937	0.00937	CcSEcCtD
Metipranolol—Arthritis—Ibandronate—osteoporosis	0.00928	0.00928	CcSEcCtD
Metipranolol—Oedema—Calcium Acetate—osteoporosis	0.00814	0.00814	CcSEcCtD
Metipranolol—Arthritis—Risedronate—osteoporosis	0.00765	0.00765	CcSEcCtD
Metipranolol—Hypertension—Ergocalciferol—osteoporosis	0.0076	0.0076	CcSEcCtD
Metipranolol—Bronchitis—Raloxifene—osteoporosis	0.00757	0.00757	CcSEcCtD
Metipranolol—Bronchitis—Ibandronate—osteoporosis	0.0075	0.0075	CcSEcCtD
Metipranolol—Atrial fibrillation—Pamidronate—osteoporosis	0.00746	0.00746	CcSEcCtD
Metipranolol—Acute coronary syndrome—Estropipate—osteoporosis	0.00714	0.00714	CcSEcCtD
Metipranolol—Myocardial infarction—Estropipate—osteoporosis	0.0071	0.0071	CcSEcCtD
Metipranolol—Conjunctivitis—Raloxifene—osteoporosis	0.00682	0.00682	CcSEcCtD
Metipranolol—Atrial fibrillation—Zoledronate—osteoporosis	0.00681	0.00681	CcSEcCtD
Metipranolol—Arthritis—Zoledronate—osteoporosis	0.00664	0.00664	CcSEcCtD
Metipranolol—Conjunctivitis—Calcitriol—osteoporosis	0.00661	0.00661	CcSEcCtD
Metipranolol—Rhinitis—Estropipate—osteoporosis	0.00652	0.00652	CcSEcCtD
Metipranolol—Bronchitis—Ethinyl Estradiol—osteoporosis	0.00634	0.00634	CcSEcCtD
Metipranolol—Rhinitis—Raloxifene—osteoporosis	0.00632	0.00632	CcSEcCtD
Metipranolol—Visual impairment—Estropipate—osteoporosis	0.00627	0.00627	CcSEcCtD
Metipranolol—Angina pectoris—Risedronate—osteoporosis	0.00626	0.00626	CcSEcCtD
Metipranolol—Bronchitis—Risedronate—osteoporosis	0.00618	0.00618	CcSEcCtD
Metipranolol—Hypersensitivity—Calcium Acetate—osteoporosis	0.006	0.006	CcSEcCtD
Metipranolol—Abnormal vision—Estradiol—osteoporosis	0.00598	0.00598	CcSEcCtD
Metipranolol—Asthenia—Calcium Acetate—osteoporosis	0.00584	0.00584	CcSEcCtD
Metipranolol—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00579	0.00579	CcSEcCtD
Metipranolol—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00576	0.00576	CcSEcCtD
Metipranolol—Conjunctivitis—Risedronate—osteoporosis	0.00557	0.00557	CcSEcCtD
Metipranolol—Tension—Estropipate—osteoporosis	0.00556	0.00556	CcSEcCtD
Metipranolol—Discomfort—Etidronic acid—osteoporosis	0.00551	0.00551	CcSEcCtD
Metipranolol—Nervousness—Estropipate—osteoporosis	0.0055	0.0055	CcSEcCtD
Metipranolol—Dizziness—Calcium Acetate—osteoporosis	0.00538	0.00538	CcSEcCtD
Metipranolol—Conjunctivitis—Pamidronate—osteoporosis	0.00529	0.00529	CcSEcCtD
Metipranolol—Rhinitis—Ethinyl Estradiol—osteoporosis	0.00529	0.00529	CcSEcCtD
Metipranolol—Bronchitis—Conjugated Estrogens—osteoporosis	0.00517	0.00517	CcSEcCtD
Metipranolol—Asthenia—Ergocalciferol—osteoporosis	0.00516	0.00516	CcSEcCtD
Metipranolol—Rhinitis—Risedronate—osteoporosis	0.00515	0.00515	CcSEcCtD
Metipranolol—Arthritis—Estradiol—osteoporosis	0.00512	0.00512	CcSEcCtD
Metipranolol—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00508	0.00508	CcSEcCtD
Metipranolol—Palpitations—Estropipate—osteoporosis	0.005	0.005	CcSEcCtD
Metipranolol—Cough—Estropipate—osteoporosis	0.00494	0.00494	CcSEcCtD
Metipranolol—Rhinitis—Pamidronate—osteoporosis	0.0049	0.0049	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00487	0.00487	CcSEcCtD
Metipranolol—Conjunctivitis—Zoledronate—osteoporosis	0.00483	0.00483	CcSEcCtD
Metipranolol—Nausea—Calcium Acetate—osteoporosis	0.00483	0.00483	CcSEcCtD
Metipranolol—Myalgia—Estropipate—osteoporosis	0.00482	0.00482	CcSEcCtD
Metipranolol—Anxiety—Estropipate—osteoporosis	0.00481	0.00481	CcSEcCtD
Metipranolol—Palpitations—Ibandronate—osteoporosis	0.0048	0.0048	CcSEcCtD
Metipranolol—Cough—Raloxifene—osteoporosis	0.00479	0.00479	CcSEcCtD
Metipranolol—Myalgia—Alendronate—osteoporosis	0.00475	0.00475	CcSEcCtD
Metipranolol—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00472	0.00472	CcSEcCtD
Metipranolol—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00469	0.00469	CcSEcCtD
Metipranolol—Discomfort—Alendronate—osteoporosis	0.00469	0.00469	CcSEcCtD
Metipranolol—Hypertension—Ibandronate—osteoporosis	0.00469	0.00469	CcSEcCtD
Metipranolol—Myalgia—Raloxifene—osteoporosis	0.00467	0.00467	CcSEcCtD
Metipranolol—Myalgia—Ibandronate—osteoporosis	0.00462	0.00462	CcSEcCtD
Metipranolol—Oedema—Estropipate—osteoporosis	0.00462	0.00462	CcSEcCtD
Metipranolol—Anxiety—Ibandronate—osteoporosis	0.00461	0.00461	CcSEcCtD
Metipranolol—Hypertension—Calcitriol—osteoporosis	0.00459	0.00459	CcSEcCtD
Metipranolol—Discomfort—Ibandronate—osteoporosis	0.00457	0.00457	CcSEcCtD
Metipranolol—Bradycardia—Zoledronate—osteoporosis	0.00455	0.00455	CcSEcCtD
Metipranolol—Myalgia—Calcitriol—osteoporosis	0.00453	0.00453	CcSEcCtD
Metipranolol—Anxiety—Calcitriol—osteoporosis	0.00451	0.00451	CcSEcCtD
Metipranolol—Discomfort—Calcitriol—osteoporosis	0.00447	0.00447	CcSEcCtD
Metipranolol—Rhinitis—Conjugated Estrogens—osteoporosis	0.00431	0.00431	CcSEcCtD
Metipranolol—Nausea—Ergocalciferol—osteoporosis	0.00427	0.00427	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00421	0.00421	CcSEcCtD
Metipranolol—Tension—Pamidronate—osteoporosis	0.00418	0.00418	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00415	0.00415	CcSEcCtD
Metipranolol—Visual impairment—Conjugated Estrogens—osteoporosis	0.00414	0.00414	CcSEcCtD
Metipranolol—Bronchitis—Estradiol—osteoporosis	0.00413	0.00413	CcSEcCtD
Metipranolol—Nervousness—Pamidronate—osteoporosis	0.00413	0.00413	CcSEcCtD
Metipranolol—Somnolence—Estropipate—osteoporosis	0.00411	0.00411	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00408	0.00408	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00404	0.00404	CcSEcCtD
Metipranolol—Cough—Ethinyl Estradiol—osteoporosis	0.00401	0.00401	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00395	0.00395	CcSEcCtD
Metipranolol—Hypersensitivity—Etidronic acid—osteoporosis	0.00394	0.00394	CcSEcCtD
Metipranolol—Cough—Risedronate—osteoporosis	0.00391	0.00391	CcSEcCtD
Metipranolol—Anxiety—Ethinyl Estradiol—osteoporosis	0.00389	0.00389	CcSEcCtD
Metipranolol—Hypertension—Risedronate—osteoporosis	0.00386	0.00386	CcSEcCtD
Metipranolol—Discomfort—Ethinyl Estradiol—osteoporosis	0.00386	0.00386	CcSEcCtD
Metipranolol—Somnolence—Calcitriol—osteoporosis	0.00386	0.00386	CcSEcCtD
Metipranolol—Myalgia—Risedronate—osteoporosis	0.00381	0.00381	CcSEcCtD
Metipranolol—Anxiety—Risedronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Metipranolol—Acute coronary syndrome—Estradiol—osteoporosis	0.00378	0.00378	CcSEcCtD
Metipranolol—Myocardial infarction—Estradiol—osteoporosis	0.00376	0.00376	CcSEcCtD
Metipranolol—Oedema—Ethinyl Estradiol—osteoporosis	0.00375	0.00375	CcSEcCtD
Metipranolol—Conjunctivitis—Estradiol—osteoporosis	0.00373	0.00373	CcSEcCtD
Metipranolol—Cough—Pamidronate—osteoporosis	0.00371	0.00371	CcSEcCtD
Metipranolol—Hypertension—Pamidronate—osteoporosis	0.00367	0.00367	CcSEcCtD
Metipranolol—Tension—Conjugated Estrogens—osteoporosis	0.00367	0.00367	CcSEcCtD
Metipranolol—Vision blurred—Zoledronate—osteoporosis	0.00366	0.00366	CcSEcCtD
Metipranolol—Nervousness—Conjugated Estrogens—osteoporosis	0.00363	0.00363	CcSEcCtD
Metipranolol—Myalgia—Pamidronate—osteoporosis	0.00362	0.00362	CcSEcCtD
Metipranolol—Epistaxis—Estradiol—osteoporosis	0.00362	0.00362	CcSEcCtD
Metipranolol—Anxiety—Pamidronate—osteoporosis	0.00361	0.00361	CcSEcCtD
Metipranolol—Discomfort—Pamidronate—osteoporosis	0.00358	0.00358	CcSEcCtD
Metipranolol—Vision blurred—Conjugated Estrogens—osteoporosis	0.00353	0.00353	CcSEcCtD
Metipranolol—Oedema—Pamidronate—osteoporosis	0.00347	0.00347	CcSEcCtD
Metipranolol—Rhinitis—Estradiol—osteoporosis	0.00345	0.00345	CcSEcCtD
Metipranolol—Palpitations—Zoledronate—osteoporosis	0.00343	0.00343	CcSEcCtD
Metipranolol—Hypersensitivity—Estropipate—osteoporosis	0.00341	0.00341	CcSEcCtD
Metipranolol—Cough—Zoledronate—osteoporosis	0.00339	0.00339	CcSEcCtD
Metipranolol—Rash—Etidronic acid—osteoporosis	0.00337	0.00337	CcSEcCtD
Metipranolol—Dermatitis—Etidronic acid—osteoporosis	0.00337	0.00337	CcSEcCtD
Metipranolol—Hypertension—Zoledronate—osteoporosis	0.00336	0.00336	CcSEcCtD
Metipranolol—Hypersensitivity—Alendronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Metipranolol—Headache—Etidronic acid—osteoporosis	0.00335	0.00335	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00333	0.00333	CcSEcCtD
Metipranolol—Asthenia—Estropipate—osteoporosis	0.00332	0.00332	CcSEcCtD
Metipranolol—Visual impairment—Estradiol—osteoporosis	0.00332	0.00332	CcSEcCtD
Metipranolol—Myalgia—Zoledronate—osteoporosis	0.00331	0.00331	CcSEcCtD
Metipranolol—Palpitations—Conjugated Estrogens—osteoporosis	0.00331	0.00331	CcSEcCtD
Metipranolol—Anxiety—Zoledronate—osteoporosis	0.0033	0.0033	CcSEcCtD
Metipranolol—Discomfort—Zoledronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Metipranolol—Asthenia—Alendronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Metipranolol—Hypersensitivity—Ibandronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Metipranolol—Cough—Conjugated Estrogens—osteoporosis	0.00327	0.00327	CcSEcCtD
Metipranolol—Dyspnoea—Risedronate—osteoporosis	0.00326	0.00326	CcSEcCtD
Metipranolol—Hypersensitivity—Calcitriol—osteoporosis	0.0032	0.0032	CcSEcCtD
Metipranolol—Myalgia—Conjugated Estrogens—osteoporosis	0.00319	0.00319	CcSEcCtD
Metipranolol—Asthenia—Ibandronate—osteoporosis	0.00318	0.00318	CcSEcCtD
Metipranolol—Anxiety—Conjugated Estrogens—osteoporosis	0.00318	0.00318	CcSEcCtD
Metipranolol—Nausea—Etidronic acid—osteoporosis	0.00317	0.00317	CcSEcCtD
Metipranolol—Oedema—Zoledronate—osteoporosis	0.00317	0.00317	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00316	0.00316	CcSEcCtD
Metipranolol—Asthenia—Calcitriol—osteoporosis	0.00311	0.00311	CcSEcCtD
Metipranolol—Dyspnoea—Pamidronate—osteoporosis	0.0031	0.0031	CcSEcCtD
Metipranolol—Somnolence—Pamidronate—osteoporosis	0.00309	0.00309	CcSEcCtD
Metipranolol—Dizziness—Estropipate—osteoporosis	0.00306	0.00306	CcSEcCtD
Metipranolol—Oedema—Conjugated Estrogens—osteoporosis	0.00305	0.00305	CcSEcCtD
Metipranolol—Dizziness—Alendronate—osteoporosis	0.00301	0.00301	CcSEcCtD
Metipranolol—Dizziness—Raloxifene—osteoporosis	0.00296	0.00296	CcSEcCtD
Metipranolol—Tension—Estradiol—osteoporosis	0.00294	0.00294	CcSEcCtD
Metipranolol—Dizziness—Ibandronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Metipranolol—Rash—Estropipate—osteoporosis	0.00291	0.00291	CcSEcCtD
Metipranolol—Dermatitis—Estropipate—osteoporosis	0.00291	0.00291	CcSEcCtD
Metipranolol—Nervousness—Estradiol—osteoporosis	0.00291	0.00291	CcSEcCtD
Metipranolol—Headache—Estropipate—osteoporosis	0.0029	0.0029	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00289	0.00289	CcSEcCtD
Metipranolol—Rash—Alendronate—osteoporosis	0.00287	0.00287	CcSEcCtD
Metipranolol—Dermatitis—Alendronate—osteoporosis	0.00287	0.00287	CcSEcCtD
Metipranolol—Headache—Alendronate—osteoporosis	0.00285	0.00285	CcSEcCtD
Metipranolol—Dyspnoea—Zoledronate—osteoporosis	0.00283	0.00283	CcSEcCtD
Metipranolol—Rash—Raloxifene—osteoporosis	0.00282	0.00282	CcSEcCtD
Metipranolol—Dermatitis—Raloxifene—osteoporosis	0.00282	0.00282	CcSEcCtD
Metipranolol—Somnolence—Zoledronate—osteoporosis	0.00282	0.00282	CcSEcCtD
Metipranolol—Headache—Raloxifene—osteoporosis	0.0028	0.0028	CcSEcCtD
Metipranolol—Rash—Ibandronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Metipranolol—Dermatitis—Ibandronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00278	0.00278	CcSEcCtD
Metipranolol—Headache—Ibandronate—osteoporosis	0.00278	0.00278	CcSEcCtD
Metipranolol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00276	0.00276	CcSEcCtD
Metipranolol—Nausea—Estropipate—osteoporosis	0.00275	0.00275	CcSEcCtD
Metipranolol—Rash—Calcitriol—osteoporosis	0.00274	0.00274	CcSEcCtD
Metipranolol—Dermatitis—Calcitriol—osteoporosis	0.00273	0.00273	CcSEcCtD
Metipranolol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00272	0.00272	CcSEcCtD
Metipranolol—Headache—Calcitriol—osteoporosis	0.00272	0.00272	CcSEcCtD
Metipranolol—Somnolence—Conjugated Estrogens—osteoporosis	0.00272	0.00272	CcSEcCtD
Metipranolol—Nausea—Alendronate—osteoporosis	0.0027	0.0027	CcSEcCtD
Metipranolol—Hypersensitivity—Risedronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Metipranolol—Asthenia—Ethinyl Estradiol—osteoporosis	0.00269	0.00269	CcSEcCtD
Metipranolol—Nausea—Raloxifene—osteoporosis	0.00266	0.00266	CcSEcCtD
Metipranolol—Palpitations—Estradiol—osteoporosis	0.00265	0.00265	CcSEcCtD
Metipranolol—Nausea—Ibandronate—osteoporosis	0.00263	0.00263	CcSEcCtD
Metipranolol—Asthenia—Risedronate—osteoporosis	0.00262	0.00262	CcSEcCtD
Metipranolol—Cough—Estradiol—osteoporosis	0.00261	0.00261	CcSEcCtD
Metipranolol—Hypertension—Estradiol—osteoporosis	0.00259	0.00259	CcSEcCtD
Metipranolol—Nausea—Calcitriol—osteoporosis	0.00258	0.00258	CcSEcCtD
Metipranolol—Hypersensitivity—Pamidronate—osteoporosis	0.00256	0.00256	CcSEcCtD
Metipranolol—Myalgia—Estradiol—osteoporosis	0.00255	0.00255	CcSEcCtD
Metipranolol—Anxiety—Estradiol—osteoporosis	0.00254	0.00254	CcSEcCtD
Metipranolol—Discomfort—Estradiol—osteoporosis	0.00252	0.00252	CcSEcCtD
Metipranolol—Asthenia—Pamidronate—osteoporosis	0.00249	0.00249	CcSEcCtD
Metipranolol—Dizziness—Ethinyl Estradiol—osteoporosis	0.00248	0.00248	CcSEcCtD
Metipranolol—Oedema—Estradiol—osteoporosis	0.00244	0.00244	CcSEcCtD
Metipranolol—Dizziness—Risedronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Metipranolol—Rash—Ethinyl Estradiol—osteoporosis	0.00236	0.00236	CcSEcCtD
Metipranolol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00236	0.00236	CcSEcCtD
Metipranolol—Headache—Ethinyl Estradiol—osteoporosis	0.00235	0.00235	CcSEcCtD
Metipranolol—Hypersensitivity—Zoledronate—osteoporosis	0.00234	0.00234	CcSEcCtD
Metipranolol—Rash—Risedronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Metipranolol—Dermatitis—Risedronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Metipranolol—Dizziness—Pamidronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Metipranolol—Headache—Risedronate—osteoporosis	0.00229	0.00229	CcSEcCtD
Metipranolol—Asthenia—Zoledronate—osteoporosis	0.00228	0.00228	CcSEcCtD
Metipranolol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00225	0.00225	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00223	0.00223	CcSEcCtD
Metipranolol—Nausea—Ethinyl Estradiol—osteoporosis	0.00223	0.00223	CcSEcCtD
Metipranolol—Asthenia—Conjugated Estrogens—osteoporosis	0.00219	0.00219	CcSEcCtD
Metipranolol—Rash—Pamidronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Metipranolol—Dermatitis—Pamidronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Metipranolol—Dyspnoea—Estradiol—osteoporosis	0.00218	0.00218	CcSEcCtD
Metipranolol—Headache—Pamidronate—osteoporosis	0.00218	0.00218	CcSEcCtD
Metipranolol—Somnolence—Estradiol—osteoporosis	0.00217	0.00217	CcSEcCtD
Metipranolol—Nausea—Risedronate—osteoporosis	0.00217	0.00217	CcSEcCtD
Metipranolol—Dizziness—Zoledronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Metipranolol—Nausea—Pamidronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Metipranolol—Dizziness—Conjugated Estrogens—osteoporosis	0.00202	0.00202	CcSEcCtD
Metipranolol—Rash—Zoledronate—osteoporosis	0.002	0.002	CcSEcCtD
Metipranolol—Dermatitis—Zoledronate—osteoporosis	0.002	0.002	CcSEcCtD
Metipranolol—Headache—Zoledronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Metipranolol—Rash—Conjugated Estrogens—osteoporosis	0.00193	0.00193	CcSEcCtD
Metipranolol—Dermatitis—Conjugated Estrogens—osteoporosis	0.00192	0.00192	CcSEcCtD
Metipranolol—Headache—Conjugated Estrogens—osteoporosis	0.00191	0.00191	CcSEcCtD
Metipranolol—Nausea—Zoledronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Metipranolol—Nausea—Conjugated Estrogens—osteoporosis	0.00181	0.00181	CcSEcCtD
Metipranolol—Hypersensitivity—Estradiol—osteoporosis	0.0018	0.0018	CcSEcCtD
Metipranolol—Asthenia—Estradiol—osteoporosis	0.00175	0.00175	CcSEcCtD
Metipranolol—Dizziness—Estradiol—osteoporosis	0.00162	0.00162	CcSEcCtD
Metipranolol—Rash—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Metipranolol—Dermatitis—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Metipranolol—Headache—Estradiol—osteoporosis	0.00153	0.00153	CcSEcCtD
Metipranolol—Nausea—Estradiol—osteoporosis	0.00145	0.00145	CcSEcCtD
